Stockscreener 앱 받기
19.12
0.47%
-0.09
전일 마감가:
$19.21
열려 있는:
$19.18
하루 거래량:
225.19K
Relative Volume:
0.64
시가총액:
$775.68M
수익:
-
순이익/손실:
$-81.05M
주가수익비율:
-7.2888
EPS:
-2.6232
순현금흐름:
$-68.97M
1주 성능:
-4.92%
1개월 성능:
-5.53%
6개월 성능:
-19.32%
1년 성능:
-28.60%
1일 변동 폭
$18.65
$19.53
1주일 범위
$18.61
$21.19
52주 변동 폭
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
명칭
Arrivent Biopharma Inc
전화
240-780-6356
주소
18 CAMPUS BLVD., NEWTOWN SQUARE
AVBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
19.12 | 779.33M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-03-20 | 개시 | B. Riley Securities | Buy |
| 2025-03-10 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2024-02-20 | 개시 | Citigroup | Buy |
| 2024-02-20 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | Jefferies | Buy |
모두보기
Arrivent Biopharma Inc 주식(AVBP)의 최신 뉴스
Published on: 2025-09-01 00:20:05 - Newser
Risk adjusted return profile for ArriVent BioPharma Inc. analyzed2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
Can ArriVent BioPharma Inc. hit a new high this monthExit Point & Consistent Return Investment Signals - Newser
What recovery options are there for ArriVent BioPharma Inc.Trade Entry Summary & Long Hold Capital Preservation Tips - Newser
Full technical analysis of ArriVent BioPharma Inc. stock2025 Big Picture & AI Powered Trade Plan Recommendations - Newser
Is this a good reentry point in ArriVent BioPharma Inc.July 2025 EndofMonth & Intraday High Probability Alerts - Newser
Will ArriVent BioPharma Inc. outperform the marketRisk Management & Technical Confirmation Alerts - Newser
How high can ArriVent BioPharma Inc. stock goJuly 2025 Levels & Technical Buy Zone Confirmations - Newser
Understanding ArriVent BioPharma Inc.’s price movement2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
ArriVent BioPharma Inc. stock prediction for this weekStop Loss & Free Weekly Watchlist of Top Performers - Newser
What machine learning models say about ArriVent BioPharma Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Volatility clustering patterns for ArriVent BioPharma Inc.Earnings Summary Report & AI Forecast Swing Trade Picks - Newser
What to expect from ArriVent BioPharma Inc. in the next 30 days2025 Biggest Moves & Precise Entry and Exit Recommendations - Newser
What are ArriVent BioPharma Inc.’s growth leversPortfolio Risk Summary & Verified Trade Idea Suggestions - sundaytimes.kr
ArriVent BioPharma Inc. Stock Recovery Path — Analyst BreakdownWeekly Investment Recap & Reliable Volume Spike Alerts - beatles.ru
ArriVent BioPharma prices $75M equity offering - MSN
Is It Too Early to Call Recovery in ArriVent BioPharma Inc. getLinesFromResByArray error: size == 0 - sisaissue.com
Visual analytics tools that track ArriVent BioPharma Inc. performanceIPO Watch & Community Verified Trade Signals - Newser
ArriVent BioPharma Inc. stock momentum explainedJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser
What indicators show strength in ArriVent BioPharma Inc.Portfolio Value Summary & Accurate Trade Setup Notifications - Newser
Arrivent Biopharma Inc (AVBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):